18/04/2019 19:26:33

CVS DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against CVS Health Corporation – CVS

NEW YORK, April 18, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of CVS Health Corporation (NYSE: CVS) from May 21, 2015 through February 20, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for CVS investors under the federal securities laws.

To join the CVS class action, go to https://pawarlawgroup.com/cases/cvs-health-corporation/ or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) CVS’s financial condition and expected earnings were deteriorating as a result of rising costs and poor results associated with its acquisition of Omnicare, Inc.; and (2) as a result, CVS’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 26, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to https://pawarlawgroup.com/cases/cvs-health-corporation/ or to discuss your rights or interests regarding this class action, please contact Vik Pawar, Esq. of Pawar Law Group toll free at 888-589-9804 or via e-mail at info@pawarlawgroup.com.

No class has been certified.  Until a class is certified, you are not represented by counsel unless you hire one.  You may hire counsel of your choice.  You may also do nothing at this time and be an absent member of the class.  Your ability to share in any future recovery is not dependent upon being a lead plaintiff. 

Pawar Law Group represents investors from around the world.

Contact:  

Vik Pawar, Esq.  

Pawar Law Group  

20 Vesey Street, Suite 1210  

New York, NY 10007  

Tel: (917) 261-2277  

Fax: (212) 571-0938  

info@pawarlawgroup.com  

Pawar-Law-Group-logo-gold.png

Related content
03:50 - 
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CVS, GVA, IFF, P..
20 Aug - 
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL:..
16 Aug - 
CLASS ACTION UPDATE for EQT, CAH and CVS: Levi & Korsin..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock
2
KLX Energy Services Reports Financial Results for Second Quarter Ended July 31, 2019; Updates Guidance
3
MYGN Loss Alert: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations
4
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2019
5
Listing of bond loan issued by Sundsvalls kommun on STO Corporate Bonds (504/19)

Related stock quotes

CVS Health Corporation 61.65 0.1% Stock price increasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 August 2019 06:58:13
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB3 - 2019-08-22 07:58:13 - 2019-08-22 06:58:13 - 1000 - Website: OKAY